Propranolol Hydrochloride Capsule, Extended Release
Product Images NDC 70518-3552

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Propranolol Hydrochloride (NDC 70518-3552). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
This is a description of Propranolol HCI extended-release capsules, with a strength of 80 mg each, packaged in a quantity of 90 capsules, and available by prescription only. The capsules are manufactured by Lannett in Bahemia, NY, and are repackaged by RemedyRepack Inc. in Indiana, PA. The medication should be kept out of the reach of children and stored at 20-25°C or 15-30°C (with excursions permitted) according to USP guidelines. Directions for use can be found in the package insert. The expiry date and lot number are not available.*
FDA Label Image

Chemical-structure (Propranolol Hydrochloride Extended Release Capsule 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.